David Berglund and Jake Doran appointed as new Board members
David Berglund is Global Head of Regulatory Operations in AstraZeneca MedImmune. Leading a global team focusing on document and submission publishing, lifecycle management of registrations, submissions and dossiers. David has been in AstraZenca for over 20 years and held several positions within Global Regulatory Affairs. He led the implementation of a consolidated RIM platform, headed the Regulatory Systems Management group and leads the reimaging of the regulatory function using new levers such as automation, robotics and AI. David is based in Gaitherburgh USA, but previously worked out of the UK and Sweden. David has a Bachelor’s Degree in Computer Science from Uppsala University Sweden.
Jake Doran is the Chief Technology Officer at Genpact Pharmalink. In this role, Jake is responsible for establishing the strategic direction and defining the design of digital solutions within the Life Sciences vertical. Prior to joining Genpact, Jake was the Founder and Managing Director of List Innovations LLC; a specialized technology development and consulting company providing Regulatory and IT solutions to the Pharmaceutical industry. Prior to that, Jake spent the first 15+ years of his career on the industry side and held executive level IT positions at both Johnson & Johnson and Schering Plough (Merck). Jake has a Bachelor’s Degree in Biological Sciences from Fairleigh Dickinson University.
Please join me in welcoming David and Jake to our board!
Hans van Bruggen
Acting chair of the IRISS BoD